Chemotherapy for gastric cancer

Por Sastre, Javier, García-Saenz, Jose Angel, Díaz-Rubio, Eduardo
Publicado em 2006

Role of cetuximab in first-line treatment of metastatic colorectal cancer

Por Sotelo, Miguel Jhonatan, García-Paredes, Beatriz, Aguado, Carlos, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2014

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

Por Aguado, Carlos, García-Paredes, Beatriz, Sotelo, Miguel Jhonatan, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2014

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients

Por Gervasini, Guillermo, García-Martín, Elena, Ladero, José M, Pizarro, Rosa, Sastre, Javier, Martínez, Carmen, García, Monserrat, Diaz-Rubio, Manuel, Agúndez, José AG
Publicado em 2007

First-Line Cetuximab Plus Capecitabine in Elderly Patients with Advanced Colorectal Cancer: Clinical Outcome and Subgroup Analysis According to KRAS Status from a Spanish TTD Group...

Por Sastre, Javier, Grávalos, Cristina, Rivera, Fernando, Massuti, Bartomeu, Valladares-Ayerbes, Manuel, Marcuello, Eugenio, Manzano, José L., Benavides, Manuel, Hidalgo, Manuel, Díaz-Rubio, Eduardo, Aranda, Enrique
Publicado em 2012

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II st...

Por Martín-Richard, Marta, Massutí, Bartomeu, Pineda, Eva, Alonso, Vicente, Marmol, Maribel, Castellano, Daniel, Fonseca, Emilio, Galán, Antonio, Llanos, Marta, Sala, Maria Angeles, Pericay, Carlos, Rivera, Fernando, Sastre, Javier, Segura, Ángel, Quindós, Maria, Maisonobe, Pascal
Publicado em 2013

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

Por Perez Villamil, Beatriz, Romera Lopez, Alejandro, Hernandez Prieto, Susana, Lopez Campos, Guillermo, Calles, Antonio, Lopez Asenjo, Jose Antonio, Sanz Ortega, Julian, Fernandez Perez, Cristina, Sastre, Javier, Alfonso, Rosario, Caldes, Trinidad, Martin Sanchez, Fernando, Diaz Rubio, Eduardo
Publicado em 2012

Circulating Tumor Cell Count Is a Prognostic Factor in Metastatic Colorectal Cancer Patients Receiving First-Line Chemotherapy Plus Bevacizumab: A Spanish Cooperative Group for the...

Por Sastre, Javier, Maestro, M. Luisa, Gómez-España, Auxiliadora, Rivera, Fernando, Valladares, Manuel, Massuti, Bartomeu, Benavides, Manuel, Gallén, Manuel, Marcuello, Eugenio, Abad, Albert, Arrivi, Antonio, Fernández-Martos, Carlos, González, Encarnación, Tabernero, Josep M., Vidaurreta, Marta, Aranda, Enrique, Díaz-Rubio, Eduardo
Publicado em 2012

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

Por Salazar, Ramon, Capdevila, Jaume, Laquente, Berta, Manzano, Jose Luis, Pericay, Carles, Villacampa, Mercedes Martínez, López, Carlos, Losa, Ferran, Safont, Maria Jose, Gómez, Auxiliadora, Alonso, Vicente, Escudero, Pilar, Gallego, Javier, Sastre, Javier, Grávalos, Cristina, Biondo, Sebastiano, Palacios, Amalia, Aranda, Enrique
Publicado no BMC Cancer (2015)

Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study

Por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Reboredo, Margarita, Manzano, José Luis, Rivera, Fernando, Safont, MªJosé, Montagut, Clara, González, Encarnación, Benavides, Manuel, Marcuello, Eugenio, Cervantes, Andrés, Martínez de Prado, Purificación, Fernández-Martos, Carlos, Arrivi, Antonio, Bando, Inmaculada
Publicado em 2012

Circulating Tumor Cells Following First Chemotherapy Cycle: An Early and Strong Predictor of Outcome in Patients With Metastatic Breast Cancer

Por Martín, Miguel, Custodio, Sara, de las Casas, Maria-Luisa Maestro, García-Sáenz, José-Ángel, de la Torre, Julio-César, Bellón-Cano, Jose-María, López-Tarruella, Sara, Vidaurreta-Lazaro, Marta, de la Orden, Virginia, Jerez, Yolanda, Márquez-Rodas, Iván, Casado, Antonio, Sastre, Javier, Díaz-Rubio, Eduardo
Publicado em 2013

First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III...

Por Díaz-Rubio, Eduardo, Gómez-España, Auxiliadora, Massutí, Bartomeu, Sastre, Javier, Abad, Albert, Valladares, Manuel, Rivera, Fernando, Safont, Maria J., Martínez de Prado, Purificación, Gallén, Manuel, González, Encarnación, Marcuello, Eugenio, Benavides, Manuel, Fernández-Martos, Carlos, Losa, Ferrán, Escudero, Pilar, Arrivi, Antonio, Cervantes, Andrés, Dueñas, Rosario, López-Ladrón, Amelia, Lacasta, Adelaida, Llanos, Marta, Tabernero, Jose M., Antón, Antonio, Aranda, Enrique
Publicado em 2012